National Brain Tumor Society funds grants for both, academic and industry researchers who have promising programs designed to advance potential therapies from research into clinical trial. All funding is open to domestic and international research communities and institutions.


The Innovation Research Grant Program supports transformative projects that will significantly move the field of brain tumor research forward. These may include "out-of-the-box" projects or new research approaches which are critical to move therapies through the drug discovery and development pipeline, more quickly. Research that represents an incremental advance is not considered innovative.

National Brain Tumor Society typically funds 1-2 Innovation Research Grants ($150,000 maximum award per year, for 2 years), and accepts Letters of Intent (LOIs) through March each year. Researchers in academic or industry labs, and at all stages of their career, may be funded through this Program.

UPDATE: Due to the overwhelming response of Letters of Intent received, the review process is taking longer than anticipated. If you have specific questions regarding your submission, you may contact Kacey Kain via email or by telephone at 520.762.4544.